Melanie Gloria
Equibles does not estimate personal net worth.
Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMVT alertsAbout Melanie Gloria
Melanie Gloria is recorded as COO at Immunovant, Inc. (IMVT). The newest filing on record that lists Melanie Gloria as COO at Immunovant, Inc. (IMVT) is dated July 22, 2026. The proxy statement of Immunovant, Inc. reports total compensation of $3,067,112 for Melanie Gloria in fiscal 2026, including a base salary of $495,000. Disclosed compensation is on record for 2 fiscal years. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed July 22, 2026
Company network
Leadership on record at Immunovant, Inc.
- Eric Venker CEO
- Eric Venker, M.D. CEO, Board Member
- Eric Venker, M.D., Pharm.D. CEO
- Dr. Frank M. Torti Chairman
- Renee Barnett CFO
- Tiago Girao CFO
- Jay S. Stout CTO
- W. Bradford Middlekauff General Counsel
- Andrew Fromkin Board Member
- Atul Pande, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Immunovant, Inc. (IMVT) | Chief Operating Officer | $495,000 | $3,067,112 |
| 2025 | Immunovant, Inc. (IMVT) | Chief Operating Officer | $180,375 | $5,573,835 |
Recent activity
No call appearances or filed executive changes recorded yet.